The new firm, TandemAI will offer partners an expanded range of methods and workflows for small-molecule and peptide drug ...

The news comes alongside the U.S. Department of Defense’s announcement of $200 million contracts awarded to xAI, Anthropic, Google and OpenAI for AI implementation.

The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.

Developing an AI platform internally can be more cost-effective and manageable, said Ryan Sadeghian, chief medical information officer at the University of Toledo, at HIMSS AI Forum.

Through the alliance, Hippocratic AI's generative AI healthcare agents will be constructed for "patient-facing non-diagnostic ...

Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, scored $73 million in a Series B funding round led by FoundersX Ventures, bringing its total ...

Unveiled at Galaxy Unpacked, the new lineup includes sleep apnea detection, vascular stress monitoring and the first ...

Constant Therapy , a digital health company specializing in speech-language Therapy, is collaborating with Burke Rehabilitation to launch an AI-powered post-acute speech therapy program for patients ...

OpenEvidence , an AI-enabled medical research aggregate platform for doctors, has scored $210 million in Series B funding, boosting the company's valuation to $3.5 billion. The round was co-led by ...

Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization ...

Researchers from Asan Medical Center, one of South Korea's largest hospitals, have developed a generative AI model that can ...

The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.